Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Silver Diamine Fluoride Gel for Early Childhood Caries
NCT06241261Phase 2Active, not recruiting
- Sponsor
- The University of Hong Kong
- Start
- Jan 2024
- Primary completion
- Aug 2027
- Modality
- Transdermal Patches, Hydrogel Systems, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, triple-blind trial of silver diamine fluoride in early childhood caries (ECC) (2 arms), sponsored by The University of Hong Kong. Primary endpoint: Hardness of cavity on tooth by probing at 30 months. Started Jan 2024; status: active, not recruiting.
02
Drugs
silver diamine fluoride
03
Conditions
early childhood caries (ECC)
Beyond the preview
Go deeper on NCT06241261.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06241261.